Patents by Inventor Jitendre D. Patel

Jitendre D. Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10098868
    Abstract: The present invention relates to the stable pharmaceutical composition of a suitable hypolipidemic agent. Preferably, the present invention discloses novel formulations of the compound of formula (I), or pharmaceutically acceptable salts of compounds of formula (I). More particularly the present invention relates to the stable pharmaceutical composition of compounds of formula (I) comprising compounds of formula (I) or its pharmaceutically acceptable salts, wherein the pH of the formulation is maintained above 7. formula (I).
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: October 16, 2018
    Assignee: Cadila Healthcare Limited
    Inventors: Jitendre D. Patel, Prakash Davadra, Snehal Patel, Shafiq Sheikh
  • Publication number: 20170266158
    Abstract: The present invention relates to the stable pharmaceutical composition of a suitable hypolipidemic agent. Preferably, the present invention discloses novel formulations of the compound of formula (I), or pharmaceutically acceptable salts of compounds of formula (I). More particularly the present invention relates to the stable pharmaceutical composition of compounds of formula (I) comprising compounds of formula (I) or its pharmaceutically acceptable salts, wherein the pH of the formulation is maintained above 7.
    Type: Application
    Filed: March 31, 2017
    Publication date: September 21, 2017
    Inventors: Jitendre D. Patel, Prakash Davadra, Snehal Patel, Shafiq Sheikh
  • Patent number: 9610277
    Abstract: The present invention relates to the stable pharmaceutical composition of a suitable hypolipidemic agent. Preferably, the present invention discloses novel formulations of the compound of formula (I), or pharmaceutically acceptable salts of compounds of formula (I). More particularly the present invention relates to the stable pharmaceutical composition of compounds of formula (I) comprising compounds of formula (I) or its pharmaceutically acceptable salts, wherein the pH of the formulation is maintained above 7.
    Type: Grant
    Filed: July 24, 2014
    Date of Patent: April 4, 2017
    Assignee: Cadila Healthcare Limited
    Inventors: Jitendre D. Patel, Prakash Davadra, Snehal Patel, Shafiq Sheikh
  • Publication number: 20160136131
    Abstract: The present invention relates to the stable pharmaceutical composition of a suitable hypolipidemic agent. Preferably, the present invention discloses novel formulations of the compound of formula (I), or pharmaceutically acceptable salts of compounds of formula (I). More particularly the present invention relates to the stable pharmaceutical composition of compounds of formula (I) comprising compounds of formula (I) or its pharmaceutically acceptable salts, wherein the pH of the formulation is maintained above 7.
    Type: Application
    Filed: July 24, 2014
    Publication date: May 19, 2016
    Applicant: Cadila Healthcare Limited
    Inventors: Jitendre D. Patel, Prakash Davadra, Snehal Patel, Shafiq Sheikh